Featured Research

from universities, journals, and other organizations

Finding new ways to treat hormone receptor-positive breast cancer

Date:
August 12, 2014
Source:
Keele University
Summary:
A leading scientist has been awarded a grant of around 20,000 by research charity Breast Cancer Campaign to find new ways to treat hormone receptor-positive breast cancer, the most common type of the disease.

A leading scientist based at Keele University in North Staffordshire has been awarded a grant of around 20,000 by research charity Breast Cancer Campaign to find new ways to treat hormone receptor-positive breast cancer, the most common type of the disease.

Up to 80% of breast cancers overproduce the oestrogen receptor (ER), and many also overproduce the progesterone receptor (PR), which drive the growth of tumours. 'Anti-hormone' drugs exist to halt the growth of these cancers, by blocking the activity of these hormone receptors, but sometimes the cancer can become resistant to these drugs. The new research by Professor Gwyn Williams and Dr. Mark Pickard will aim to find new ways to stop these hormone receptors working, which could lead to new treatments for this type of breast cancer.

In the West Midlands breast cancer is the most common cancer in women, with nearly 4,400 new cases diagnosed every year, and over 1,000 women sadly dying from the disease each year on average.

Professor Williams said: "Hormone receptor-positive breast cancer can sometimes become resistant to the drugs used to treat it. The grant I have received from Breast Cancer Campaign will enable me to find new ways to prevent the growth of these breast cancers, which could ultimately lead to new ways to treat the disease and ultimately save lives." ER or PR are overproduced in the cells of up to 80% of breast tumours and once activated cause the cancer cells to multiply, driving tumour growth. They do this by binding to the DNA in places that have specific genetic codes, and activating genes that cause the cell to multiply and survive.

Professor Williams and Dr. Pickard will create short pieces of DNA in the lab which could act as 'decoys', mimicking the parts of DNA that ER or PR would normally bind to. These could then be used like drugs to block ER or PR from binding to the breast cancer cell's DNA, and so prevent them from driving the growth of breast cancer. Professor Williams and Dr. Pickard will test whether ER and PR bind to these fragments, and study what effect they have on breast cancer cells grown in the lab.

Katherine Woods, Research Communications Manager at Breast Cancer Campaign, said: "Professor Williams' research into this area is vital and could ultimately lead to new treatments to slow down the growth of breast cancers that overproduce ER or PR, the most common form of the disease."

"This would improve the chances of survival for thousands of patients and bring us one step closer to our goal that by 2030 we will have identified what causes different tumours to grow and progress -- enabling us to select the best treatment for every patient."


Story Source:

The above story is based on materials provided by Keele University. Note: Materials may be edited for content and length.


Cite This Page:

Keele University. "Finding new ways to treat hormone receptor-positive breast cancer." ScienceDaily. ScienceDaily, 12 August 2014. <www.sciencedaily.com/releases/2014/08/140812121926.htm>.
Keele University. (2014, August 12). Finding new ways to treat hormone receptor-positive breast cancer. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2014/08/140812121926.htm
Keele University. "Finding new ways to treat hormone receptor-positive breast cancer." ScienceDaily. www.sciencedaily.com/releases/2014/08/140812121926.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins